Granahan Investment Management REVANCE THERAPEUTICS INC ownership

Watchlist

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 127 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Granahan Investment Management ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$3,153
-10.8%
161,695
-25.3%
0.08%
+6.8%
Q4 2021$3,533
-1.1%
216,497
+68.8%
0.07%
+7.4%
Q3 2021$3,573–128,239–0.07%–
 Download

External links